Fidji Simo said Thursday that she would leave her full-time product-and-business role at OpenAI to focus on recovery from a severe exacerbation of a chronic illness and become a part-time adviser, according to Reuters, CNBC and TechCrunch. [1][2][3]

The transition follows the paper's July 8 account of OpenAI pursuing a trillion-dollar listing behind a sealed filing, which kept projected 2026 losses separate from audited 2025 losses and said the private S-1 prevented public reconciliation of the company's finances and compute obligations, leaving Simo's departure to add an execution question without changing those figures or opening those books.

Simo gave a health reason, and the record permits no alternate motive, diagnosis or prognosis, although a departure described by outlets as removing OpenAI's No. 2 executive or applications leader leaves objective organizational questions about who assumes product and business responsibilities, when the full-time role ends, and what authority remains with a part-time adviser.

Reuters, CNBC and TechCrunch properly place her stated illness first, while searches aimed at OpenAI's developer community found no verified X post supporting intrigue or any motive beyond Simo's account.

OpenAI now owes mundane answers about reporting lines, product ownership and commercial accountability, details that can establish how the work moves and whether a leadership gap exists but cannot explain Simo's health or transform an organizational vacancy into evidence of a concealed dispute.

-- PRIYA SHARMA, Delhi